AEM vs AU

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite robust profitability metrics—ROE of 38.71%, operating margin of 42.49%, and strong YoY earnings growth of 147.2%—the stock trades at a premium valuation with a P/E of 22.56 and Price/Book of 6.98, above sector averages. Persistent earnings misses over the last four quarters and a weak technical trend score of 10/100 suggest caution, even as analyst consensus remains at 'buy'. The current price of $106.26 sits above the Graham Number of $40.18, reflecting high growth expectations rather than defensive value.